Academic Partners

  • Rheinische Friedrich-Wilhelms-University Bonn
  • Research Center Jülich
  • Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V., Fraunhofer Institute for Algorithms and Scientific Computing SCAI
  • University Hospitals Bonn
  • University Hospitals Essen
  • Helmholtz Center Dresden-Rossendorf (HZDR)
  • Eberhard Karls Universität Tübingen
  • University Hospital Tübingen
  • Georg-August-University Göttingen
  • Charité - Universitätsmedizin Berlin

Industrial Partners

  • UCB Pharma GmbH
  • Life & Brain GmbH
  • IBL International GmbH
  • Cube Biotech GmbH
  • Pharmacelsus GmbH
  • Piramal Imaging GmbH
  • ROTOP Pharmaka AG
  • ratiopharm GmbH
  • Immungenetics AG
  • jung diagnostics GmbH
© Fotolia – auremar


To provide the German location of biotechnology and pharma industry with fresh impulsion, the German Federal Ministry for Education and Research (BMBF) started the pharma initiative "BioPharma: The Strategy Competition for Future Medicines". The Neuroallianz Consortium was nominated for this initiative.

The Neuroallianz Consortium has created a novel strategic partnership where various academic institutions and companies are working jointly on innovative diagnostic and therapeutic research projects. The aim is to efficiently transform research into benefits for the patients.

Main focuses are diagnostic and therapy of neurodegenerative diseases such as Parkinson's Disease, or Alzheimer's Dementia, and Epilepsy.

Duration: 2009 – 2018

Budget: 40 Mio. €